Dr. Reddy's Laboratories Limited (RDY)

NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
$14.89+0.40%As of 2026-11-22 · USD
Last session low $14.86Last session high $15.10
52-week low $11.3652-week high $15.67
Market cap
$12.41B
Sector
Healthcare
P/E (TTM)
41.4x
Dividend yield
0.56%
Next earnings
2027-01-21 (est.)

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)68.9In the neutral range (30 to 70)
MACD (12, 26, 9)0.46Below its signal line (0.50); histogram -0.04
Bollinger %B (20, 2)71%Inside the bands (13.75 to 15.35)
SMA 2014.55Price is 2.3% above
SMA 5013.34Price is 11.6% above
SMA 20013.31Price is 11.9% above
ATR (20)1.88% of priceAverage true range per day
52-week position82%In the upper part of the 11.36 to 15.67 range

About Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment.

Latest fiscal yearEnded 2026-03-31: revenue of 335.93B INR and an operating margin of 14.9%.
Next earnings reportExpected on 2027-01-21 (the date is an estimate).

Also listed as DRREDDY.NS (NSE)

More in Drug Manufacturers - Specialty & Generic